| | | |
PER SHARE OF
COMMON STOCK AND ACCOMPANYING COMMON STOCK WARRANT |
| |
PER
PRE-FUNDED WARRANT AND ACCOMPANYING COMMON STOCK WARRANT |
| |
TOTAL
|
| |||||||||
|
Public offering price
|
| | | $ | 6.5140 | | | | | $ | 6.5130 | | | | | $ | 63,998,400.74 | | |
|
Underwriting discounts and commissions(1)
|
| | | $ | 0.39084 | | | | | $ | 0.39078 | | | | | $ | 3,839,904.04 | | |
|
Proceeds to us, before expenses
|
| | | $ | 6.12316 | | | | | $ | 6.12222 | | | | | $ | 60,158,496.70 | | |
| Jefferies | | |
Evercore ISI
|
|
| LifeSci Capital | | |
Oppenheimer & Co.
|
|
| Table of Contents | | | |||||
| Prospectus Supplement | | | | | | | |
| | | | | S-1 | | | |
| | | | | S-3 | | | |
| | | | | S-3 | | | |
| | | | | S-4 | | | |
| | | | | S-6 | | | |
| | | | | S-9 | | | |
| | | | | S-11 | | | |
| | | | | S-13 | | | |
| | | | | S-14 | | | |
| | | | | S-15 | | | |
| | | | | S-17 | | | |
| | | | | S-19 | | | |
| | | | | S-22 | | | |
| | | | | S-29 | | | |
| | | | | S-36 | | | |
| | | | | S-36 | | | |
| Prospectus | | | | | | | |
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 2 | | | |
| | | | | 3 | | | |
| | | | | 5 | | | |
| | | | | 4 | | | |
| | | | | 6 | | | |
| | | | | 7 | | | |
| | | | | 15 | | | |
| | | | | 18 | | | |
| | | | | 19 | | | |
| | | | | 20 | | | |
| | | | | 22 | | | |
| | | | | 24 | | | |
| | | | | 24 | | |
| | |
AS OF JUNE 30, 2023
|
| |||||||||
| | |
ACTUAL
|
| |
AS
ADJUSTED |
| ||||||
| | |
(in thousands,
except share and per share data) (unaudited) |
| |||||||||
Cash, cash equivalents and short-term investments
|
| | | $ | 202,958 | | | | | $ | 262,576 | | |
Stockholders’ equity: | | | | | | | | | | | | | |
Preferred stock, $0.001 par value per share, 4,908,620 shares authorized and no shares issued and outstanding
|
| | | | — | | | | | | — | | |
Series X convertible preferred stock, $0.001 par value per share, 91,380 shares authorized, 31,107 shares issued and outstanding
|
| | | | 95,324 | | | | | | 95,324 | | |
Common stock, $0.001 par value per share, 150,000,000 shares authorized;
28,025,844 shares issued and outstanding, actual; 36,279,739 shares issued and outstanding, as adjusted |
| | | | 28 | | | | | | 36 | | |
Additional paid-in capital
|
| | | | 636,447 | | | | | | 696,057 | | |
Accumulated other comprehensive loss
|
| | | | — | | | | | | — | | |
Accumulated deficit
|
| | | | (531,397) | | | | | | (531,397) | | |
Total stockholders’ equity
|
| | | | 200,402 | | | | | | 260,020 | | |
Total capitalization
|
| | | $ | 200,402 | | | | | $ | 260,020 | | |
|
|
Combined public offering price per share of common stock and accompanying common stock warrant
|
| | | | | | | | | $ | 6.514 | | |
|
Historical net tangible book value per share of common stock as of June 30, 2023
|
| | | $ | 7.15 | | | | | | | | |
|
Pro forma net tangible book value per share as of June 30, 2023
|
| | | $ | 6.03 | | | | | | | | |
|
Increase in pro forma net tangible book value per share of common stock attributable to
new investors participating in this offering |
| | | $ | 0.24 | | | | | | | | |
|
Pro forma as adjusted net tangible book value per share of common stock immediately after this offering
|
| | | | | | | | | $ | 6.27 | | |
|
Dilution per share of common stock to new investors participating in this offering
|
| | | | | | | | | $ | 0.24 | | |
|
UNDERWRITERS
|
| |
NUMBER OF
SHARES OF COMMON STOCK |
| |
NUMBER OF
PRE-FUNDED WARRANTS |
| |
NUMBER OF
ACCOMPANYING COMMON STOCK WARRANTS |
| |||||||||
Jefferies LLC
|
| | | | 3,714,253 | | | | | | 706,992 | | | | | | 3,315,932 | | |
Evercore Group L.L.C.
|
| | | | 2,888,864 | | | | | | 549,883 | | | | | | 2,579,058 | | |
LifeSci Capital LLC
|
| | | | 825,389 | | | | | | 157,109 | | | | | | 736,874 | | |
Oppenheimer & Co. Inc.
|
| | | | 825,389 | | | | | | 157,109 | | | | | | 736,874 | | |
Total
|
| | | | 8,253,895 | | | | | | 1,571,093 | | | | | | 7,368,738 | | |
|
| | |
PER SHARE OF
COMMON STOCK AND ACCOMPANYING COMMON STOCK WARRANT |
| |
PER PRE-FUNDED
WARRANT AND ACCOMPANYING COMMON STOCK WARRANT |
| |
TOTAL
|
| |||||||||
Public offering price
|
| | | $ | 6.514 | | | | | $ | 6.513 | | | | | $ | 63,998,400.74 | | |
Underwriting discounts and commissions
|
| | | $ | 0.39084 | | | | | $ | 0.39078 | | | | | $ | 3,839,904.04 | | |
Proceeds to us, before expenses
|
| | | $ | 6.12316 | | | | | $ | 6.12222 | | | | | $ | 60,158,496.70 | | |
|
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 2 | | | |
| | | | | 3 | | | |
| | | | | 4 | | | |
| | | | | 5 | | | |
| | | | | 6 | | | |
| | | | | 7 | | | |
| | | | | 15 | | | |
| | | | | 18 | | | |
| | | | | 19 | | | |
| | | | | 20 | | | |
| | | | | 22 | | | |
| | | | | 24 | | | |
| | | | | 24 | | |